The FDA Nixes a Pathbreaking Drug for MS

The FDA Nixes a Pathbreaking Drug for MS

It was sickening to watch the FDA deny an obviously effective and important therapy to those afflicted with a terrible disease. For as long as the decision stands, much needless suffering will result (and much needless foreign travel). The agency's

2
Like
Save

Comments

Write a comment

*